Back
  1. Home
  2. Profile
Profil

Vamecq Joseph


Main Referenced Co-authors
Vanden Eynde, Jean-Jacques  (3)
Gressens, Pierre (2)
Maurois, Pierre (2)
Stanicki, Dimitri  (2)
Bac, Pierre (1)
Main Referenced Disciplines
Pharmacy, pharmacology & toxicology (3)
Chemistry (2)
Endocrinology, metabolism & nutrition (1)

Publications (total 3)

The most cited
23 citations (Scopus®)
Vamecq, J., Colet, J.-M., Vanden Eynde, J.-J., Briand, G., Porchet, N., & Rocchi, S. (19 February 2012). PPARs: Interference with Warburg' Effect and Clinical Anticancer Trials. PPAR Research, 2012 (304760), 23. doi:10.1155/2012/304760 https://hdl.handle.net/20.500.12907/23683

Vamecq, J., Colet, J.-M., Vanden Eynde, J.-J., Briand, G., Porchet, N., & Rocchi, S. (19 February 2012). PPARs: Interference with Warburg' Effect and Clinical Anticancer Trials. PPAR Research, 2012 (304760), 23. doi:10.1155/2012/304760
Peer Reviewed verified by ORBi

Vamecq, J., Maurois, P., Pages, N., Bac, P., Stables, J. P., Gressens, P., Stanicki, D., & Vanden Eynde, J.-J. (29 March 2010). 1, 2-Ethane bis-1-amino-4-benzamidine is Active Against Several Brain Insult and Seizure Challenges Through Anti-NMDA Mechanisms Targeting the 3H-TCP Binding Site and Antioxidant Action. European Journal of Medicinal Chemistry, 45, 3101-3110.
Peer Reviewed verified by ORBi

Vanden Eynde, J.-J., Stanicki, D., Maurois, P., Vamecq, J., & Gressens, P. (01 January 2009). Bisbenzamidine Derivatives for Use as Antioxidant.

Contact ORBi